April 13, 2015 | The international biomed fund OrbiMed is considering raising a second fund in Israel, according to a “Globes” report. OrbiMed reportedly hopes to raise between $200-250 million, though the group has not yet begun recruiting investors. In Israel, OrbiMed is headed by Senior Managing Director Dr. Nissim Darvish together with Anat Naschitz and Erez Chimovits, among others.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments